Skip to main content
. 2020 Jul 29;7(5):2146–2174. doi: 10.1002/ehf2.12782
Study source Confounders
Kim (2019) 134 Age, (gender), BMI, SBP, HR, HT, CHD, Hb, Na, Cre, NT‐proBNP, LVEF, medications
Chen (2018) 101 None
Cooper (2018) 102 Age, gender, race, BMI, SBP, HrR, NYHA, CHD, AF, PVD, COPD, CKD, ACE‐I, ARB, diuretics
Iorio (2018) 137 Age, gender
Kristensen (2018) 103 None
Retwinski (2018) 136 None
Rorth (2018) 104 Age, gender, education, IHD, AF, CKD, COPD, HT, stroke, cancer, medications
Sandesara (2018) 105 None
Takimura (2018) 135 Age, duration after previous HF, Hb, UA, LVEF, LAVI
Dauriz (2017) 106 Age, gender, smoking, BMI, SBP, eGFR, LVEF, IHD, HT, statin, stroke, COPD, Hb
Farre (2017) 107 Age, gender, recent HF, anaemia, valvular disease, IHD, CKD, dialysis, AF, cardiac conduction disorders, cancer, stroke, dementia, cirrhosis number of hospitalization, visits to emergency department
Kristensen (2017) 108 Age, gender, recent HF, LVEF, HrR, eGFR, NT‐proBNP, neutrophils, COPD, MI, ischaemic origin
Mohamedali (2017) 109 None
Echouffo‐Tcheugui (2016) 110 Age, gender, race, LVEF, NYHA, AF, ischaemic cardiomyopathy, ECG (LBBB, wide QRS), cardiac conduction disorders, HF duration, Cre, history of syncope, FH of sudden death, CHD, ventricular tachycardia medications
Kristensen (2016) 111 None
Ruigomez (2016) 112 Age, gender, smoking, alcohol, BMI, residence, IHD, stroke, HT, AF, hyperlipidaemia, COPD, asthma, RD, visiting hospital in the previous year
Kaneko (2015) 113 Age, IHD, DBP, HrR, diuretics
Takeda (2015) 114 None
Carrasco‐Sanchez (2014) 115 Age, NYHA, GFR, Na, BMI, anaemia, PVD, beta‐blocker, ACE‐Is, ARBs
Cubbon (2014) 116 Pulmonary congestion, previous HF, diuretics
Paoletti (2014) 117 None
Sakata (2014) 118 Age, gender, smoking, BMI, SBP, HT, dyslipidaemia, LVEF, HrR, Hb, Cre, BNP, medications
Larina (2013) 119 None
Sarma (2013) 120 Age, gender, smoking, BMI, SBP, EF, Na, BUN, QRS duration, BNP/NT‐proBNP, AF, HT, CKD, stroke, medications
Verbrugge (2012) 121 Obesity, HT, COPD, CKD, NYHA, right ventricular function, ischaemic aetiology of HF
Deedwania (2011) 122 Propensity‐matched for age, gender, smoking, BMI, SBP, DBP, HrR, others (multiple) (previous diseases, laboratory data, medications)
Martin (2011) 123 None
Aguilar (2010) 124 Age, gender, obesity, ischaemic origin, NYHA
Sze (2010) 125 Gender, NYHA, AF, wide QRS, HrR, one of renal function indicators, beta‐blocker, diuretics
MacDonald (2008) 126 32 covariates (including age, gender, smoking, SBP, DBP, NYHA, LVEF, HrR, IHD, stroke, AT, pacemaker, various medications)
Macdonald (2008) 127 Age, (gender), co‐morbidities (including CHD)
Ghali (2007) 128 None
Ruiz‐Ruiz (2007) 129 None
Formiga (2006) 130 Age, gender, SBP, PIP
Garcia (2005) 131 None
Domanski (2003) 132 Age, gender, BMI, race, Cre, SBP, aetiology of HF, cholesterol, diuretics, vasodilators
Shindler (1996) 133 Age, gender, race, EF, aetiology of left ventricular dysfunction, NYHA
Harnett (1995) 85 Age, IHD, EF, Hb, albumin, DBP, LV mass